Dominic Paniccia Becomes New CEO at Integra Partners

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

Dominic Paniccia has been appointed new CEO effective March 31, 2019. Paniccia succeeds Andrew Saltoun, who will continue to serve as a senior advisor to the organization.

Paniccia joined Integra Partners in 2016, first serving as chief financial officer, and was appointed president in 2018, assuming the day-to-day activities of the organization. In the past year under his leadership, the company has seen significant growth and looks to continue upon that progress as it continues to expand its network.  Among Paniccia’s more recent achievements at Integra is the creation of a new customer-centric model which has improved operations and increased revenues.

Tom Croswell, president and CEO of Tufts Health Plan, and an Integra Partners board director, said: “This is a great time in the history of Integra Partners.  We are grateful to Andrew for bringing the company to where it is today, and we are looking forward to working with Dom and his team to continue upon the positive results and momentum they have achieved in the past year.”

“I’m honored to be appointed to this position,” said Paniccia.  “Integra is growing, and we’re focused on doing what we can to achieve our mission of reducing the friction in health care – making things easier for our clients, which includes health plans and providers – as we manage these benefits.”

Paniccia’s career has spanned several industries, including financial services, information management and health care.  Prior to joining Integra Partners, he held leadership positions at American Express, AIG and CB Insights. He earned his M.B.A from Fordham University and his B.S. from Manhattan College.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.